nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—CYP1A2—Estropipate—osteoporosis	0.0655	0.53	CbGbCtD
Pentoxifylline—CYP1A2—Conjugated Estrogens—osteoporosis	0.031	0.251	CbGbCtD
Pentoxifylline—CYP1A2—Estradiol—osteoporosis	0.0272	0.22	CbGbCtD
Pentoxifylline—NT5E—periosteum—osteoporosis	0.0184	0.766	CbGeAlD
Pentoxifylline—NT5E—uterus—osteoporosis	0.00251	0.105	CbGeAlD
Pentoxifylline—NT5E—bone marrow—osteoporosis	0.00213	0.0889	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—osteoporosis	0.00097	0.0405	CbGeAlD
Pentoxifylline—Infection—Pamidronate—osteoporosis	0.000657	0.00121	CcSEcCtD
Pentoxifylline—Urticaria—Calcitriol—osteoporosis	0.000656	0.0012	CcSEcCtD
Pentoxifylline—Haemorrhage—Estradiol—osteoporosis	0.000655	0.0012	CcSEcCtD
Pentoxifylline—Hepatitis—Estradiol—osteoporosis	0.000655	0.0012	CcSEcCtD
Pentoxifylline—Palpitations—Zoledronate—osteoporosis	0.000654	0.0012	CcSEcCtD
Pentoxifylline—Abdominal pain—Calcitriol—osteoporosis	0.000653	0.0012	CcSEcCtD
Pentoxifylline—Body temperature increased—Calcitriol—osteoporosis	0.000653	0.0012	CcSEcCtD
Pentoxifylline—Angioedema—Conjugated Estrogens—osteoporosis	0.000651	0.0012	CcSEcCtD
Pentoxifylline—Shock—Pamidronate—osteoporosis	0.00065	0.00119	CcSEcCtD
Pentoxifylline—Hypersensitivity—Estropipate—osteoporosis	0.000648	0.00119	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Pamidronate—osteoporosis	0.000647	0.00119	CcSEcCtD
Pentoxifylline—Vomiting—Etidronic acid—osteoporosis	0.000647	0.00119	CcSEcCtD
Pentoxifylline—Tachycardia—Pamidronate—osteoporosis	0.000645	0.00118	CcSEcCtD
Pentoxifylline—Rash—Etidronic acid—osteoporosis	0.000641	0.00118	CcSEcCtD
Pentoxifylline—Convulsion—Zoledronate—osteoporosis	0.000641	0.00118	CcSEcCtD
Pentoxifylline—Dermatitis—Etidronic acid—osteoporosis	0.000641	0.00118	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Pamidronate—osteoporosis	0.000639	0.00117	CcSEcCtD
Pentoxifylline—Hypertension—Zoledronate—osteoporosis	0.000639	0.00117	CcSEcCtD
Pentoxifylline—Hypersensitivity—Alendronate—osteoporosis	0.000638	0.00117	CcSEcCtD
Pentoxifylline—Headache—Etidronic acid—osteoporosis	0.000637	0.00117	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000633	0.00116	CcSEcCtD
Pentoxifylline—Asthenia—Estropipate—osteoporosis	0.000631	0.00116	CcSEcCtD
Pentoxifylline—Anorexia—Pamidronate—osteoporosis	0.00063	0.00116	CcSEcCtD
Pentoxifylline—Myalgia—Zoledronate—osteoporosis	0.00063	0.00116	CcSEcCtD
Pentoxifylline—Chest pain—Zoledronate—osteoporosis	0.00063	0.00116	CcSEcCtD
Pentoxifylline—Palpitations—Conjugated Estrogens—osteoporosis	0.000629	0.00116	CcSEcCtD
Pentoxifylline—Insomnia—Risedronate—osteoporosis	0.000629	0.00115	CcSEcCtD
Pentoxifylline—Anxiety—Zoledronate—osteoporosis	0.000628	0.00115	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000625	0.00115	CcSEcCtD
Pentoxifylline—Pruritus—Estropipate—osteoporosis	0.000622	0.00114	CcSEcCtD
Pentoxifylline—Discomfort—Zoledronate—osteoporosis	0.000622	0.00114	CcSEcCtD
Pentoxifylline—Asthenia—Alendronate—osteoporosis	0.000622	0.00114	CcSEcCtD
Pentoxifylline—Hypersensitivity—Ibandronate—osteoporosis	0.000622	0.00114	CcSEcCtD
Pentoxifylline—Dyspnoea—Risedronate—osteoporosis	0.00062	0.00114	CcSEcCtD
Pentoxifylline—Hypotension—Pamidronate—osteoporosis	0.000618	0.00113	CcSEcCtD
Pentoxifylline—Convulsion—Conjugated Estrogens—osteoporosis	0.000617	0.00113	CcSEcCtD
Pentoxifylline—Dry mouth—Zoledronate—osteoporosis	0.000616	0.00113	CcSEcCtD
Pentoxifylline—Pruritus—Alendronate—osteoporosis	0.000613	0.00113	CcSEcCtD
Pentoxifylline—Dyspepsia—Risedronate—osteoporosis	0.000612	0.00112	CcSEcCtD
Pentoxifylline—Constipation—Ethinyl Estradiol—osteoporosis	0.00061	0.00112	CcSEcCtD
Pentoxifylline—Confusional state—Zoledronate—osteoporosis	0.000609	0.00112	CcSEcCtD
Pentoxifylline—Hypersensitivity—Calcitriol—osteoporosis	0.000608	0.00112	CcSEcCtD
Pentoxifylline—Flushing—Estradiol—osteoporosis	0.000608	0.00112	CcSEcCtD
Pentoxifylline—Myalgia—Conjugated Estrogens—osteoporosis	0.000606	0.00111	CcSEcCtD
Pentoxifylline—Chest pain—Conjugated Estrogens—osteoporosis	0.000606	0.00111	CcSEcCtD
Pentoxifylline—Asthenia—Ibandronate—osteoporosis	0.000605	0.00111	CcSEcCtD
Pentoxifylline—Anxiety—Conjugated Estrogens—osteoporosis	0.000604	0.00111	CcSEcCtD
Pentoxifylline—Nausea—Etidronic acid—osteoporosis	0.000604	0.00111	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Zoledronate—osteoporosis	0.000604	0.00111	CcSEcCtD
Pentoxifylline—Oedema—Zoledronate—osteoporosis	0.000604	0.00111	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000602	0.00111	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000602	0.00111	CcSEcCtD
Pentoxifylline—Diarrhoea—Estropipate—osteoporosis	0.000602	0.00111	CcSEcCtD
Pentoxifylline—Infection—Zoledronate—osteoporosis	0.0006	0.0011	CcSEcCtD
Pentoxifylline—Insomnia—Pamidronate—osteoporosis	0.000598	0.0011	CcSEcCtD
Pentoxifylline—Pruritus—Ibandronate—osteoporosis	0.000597	0.0011	CcSEcCtD
Pentoxifylline—Constipation—Risedronate—osteoporosis	0.000595	0.00109	CcSEcCtD
Pentoxifylline—Shock—Zoledronate—osteoporosis	0.000594	0.00109	CcSEcCtD
Pentoxifylline—Diarrhoea—Alendronate—osteoporosis	0.000593	0.00109	CcSEcCtD
Pentoxifylline—Asthenia—Calcitriol—osteoporosis	0.000593	0.00109	CcSEcCtD
Pentoxifylline—Immune system disorder—Estradiol—osteoporosis	0.000591	0.00109	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Zoledronate—osteoporosis	0.000591	0.00109	CcSEcCtD
Pentoxifylline—Dyspnoea—Pamidronate—osteoporosis	0.000589	0.00108	CcSEcCtD
Pentoxifylline—Tachycardia—Zoledronate—osteoporosis	0.000589	0.00108	CcSEcCtD
Pentoxifylline—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000588	0.00108	CcSEcCtD
Pentoxifylline—Somnolence—Pamidronate—osteoporosis	0.000588	0.00108	CcSEcCtD
Pentoxifylline—Skin disorder—Zoledronate—osteoporosis	0.000586	0.00108	CcSEcCtD
Pentoxifylline—Pruritus—Calcitriol—osteoporosis	0.000584	0.00107	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Zoledronate—osteoporosis	0.000584	0.00107	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000583	0.00107	CcSEcCtD
Pentoxifylline—Diarrhoea—Raloxifene—osteoporosis	0.000583	0.00107	CcSEcCtD
Pentoxifylline—Dyspepsia—Pamidronate—osteoporosis	0.000582	0.00107	CcSEcCtD
Pentoxifylline—Dizziness—Estropipate—osteoporosis	0.000582	0.00107	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000581	0.00107	CcSEcCtD
Pentoxifylline—Oedema—Conjugated Estrogens—osteoporosis	0.000581	0.00107	CcSEcCtD
Pentoxifylline—Infection—Conjugated Estrogens—osteoporosis	0.000578	0.00106	CcSEcCtD
Pentoxifylline—Diarrhoea—Ibandronate—osteoporosis	0.000577	0.00106	CcSEcCtD
Pentoxifylline—Anorexia—Zoledronate—osteoporosis	0.000575	0.00106	CcSEcCtD
Pentoxifylline—Decreased appetite—Pamidronate—osteoporosis	0.000575	0.00106	CcSEcCtD
Pentoxifylline—Dizziness—Alendronate—osteoporosis	0.000573	0.00105	CcSEcCtD
Pentoxifylline—Shock—Conjugated Estrogens—osteoporosis	0.000572	0.00105	CcSEcCtD
Pentoxifylline—Erythema—Estradiol—osteoporosis	0.00057	0.00105	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Risedronate—osteoporosis	0.000569	0.00104	CcSEcCtD
Pentoxifylline—Tachycardia—Conjugated Estrogens—osteoporosis	0.000567	0.00104	CcSEcCtD
Pentoxifylline—Urticaria—Ethinyl Estradiol—osteoporosis	0.000567	0.00104	CcSEcCtD
Pentoxifylline—Constipation—Pamidronate—osteoporosis	0.000565	0.00104	CcSEcCtD
Pentoxifylline—Diarrhoea—Calcitriol—osteoporosis	0.000565	0.00104	CcSEcCtD
Pentoxifylline—Skin disorder—Conjugated Estrogens—osteoporosis	0.000565	0.00104	CcSEcCtD
Pentoxifylline—Hypotension—Zoledronate—osteoporosis	0.000564	0.00104	CcSEcCtD
Pentoxifylline—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000564	0.00104	CcSEcCtD
Pentoxifylline—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000564	0.00104	CcSEcCtD
Pentoxifylline—Dizziness—Raloxifene—osteoporosis	0.000564	0.00103	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000562	0.00103	CcSEcCtD
Pentoxifylline—Flatulence—Estradiol—osteoporosis	0.000562	0.00103	CcSEcCtD
Pentoxifylline—Tension—Estradiol—osteoporosis	0.000559	0.00103	CcSEcCtD
Pentoxifylline—Vomiting—Estropipate—osteoporosis	0.000559	0.00103	CcSEcCtD
Pentoxifylline—Dysgeusia—Estradiol—osteoporosis	0.000558	0.00103	CcSEcCtD
Pentoxifylline—Dizziness—Ibandronate—osteoporosis	0.000558	0.00102	CcSEcCtD
Pentoxifylline—Rash—Estropipate—osteoporosis	0.000555	0.00102	CcSEcCtD
Pentoxifylline—Dermatitis—Estropipate—osteoporosis	0.000554	0.00102	CcSEcCtD
Pentoxifylline—Anorexia—Conjugated Estrogens—osteoporosis	0.000554	0.00102	CcSEcCtD
Pentoxifylline—Nervousness—Estradiol—osteoporosis	0.000554	0.00102	CcSEcCtD
Pentoxifylline—Urticaria—Risedronate—osteoporosis	0.000552	0.00101	CcSEcCtD
Pentoxifylline—Back pain—Estradiol—osteoporosis	0.000551	0.00101	CcSEcCtD
Pentoxifylline—Headache—Estropipate—osteoporosis	0.000551	0.00101	CcSEcCtD
Pentoxifylline—Vomiting—Alendronate—osteoporosis	0.000551	0.00101	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00055	0.00101	CcSEcCtD
Pentoxifylline—Body temperature increased—Risedronate—osteoporosis	0.00055	0.00101	CcSEcCtD
Pentoxifylline—Abdominal pain—Risedronate—osteoporosis	0.00055	0.00101	CcSEcCtD
Pentoxifylline—Muscle spasms—Estradiol—osteoporosis	0.000548	0.00101	CcSEcCtD
Pentoxifylline—Rash—Alendronate—osteoporosis	0.000546	0.001	CcSEcCtD
Pentoxifylline—Insomnia—Zoledronate—osteoporosis	0.000546	0.001	CcSEcCtD
Pentoxifylline—Dermatitis—Alendronate—osteoporosis	0.000546	0.001	CcSEcCtD
Pentoxifylline—Feeling abnormal—Pamidronate—osteoporosis	0.000545	0.001	CcSEcCtD
Pentoxifylline—Hypotension—Conjugated Estrogens—osteoporosis	0.000543	0.000998	CcSEcCtD
Pentoxifylline—Headache—Alendronate—osteoporosis	0.000543	0.000997	CcSEcCtD
Pentoxifylline—Vomiting—Raloxifene—osteoporosis	0.000542	0.000995	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Pamidronate—osteoporosis	0.00054	0.000993	CcSEcCtD
Pentoxifylline—Dyspnoea—Zoledronate—osteoporosis	0.000538	0.000988	CcSEcCtD
Pentoxifylline—Rash—Raloxifene—osteoporosis	0.000537	0.000987	CcSEcCtD
Pentoxifylline—Dermatitis—Raloxifene—osteoporosis	0.000537	0.000986	CcSEcCtD
Pentoxifylline—Somnolence—Zoledronate—osteoporosis	0.000537	0.000986	CcSEcCtD
Pentoxifylline—Vomiting—Ibandronate—osteoporosis	0.000536	0.000985	CcSEcCtD
Pentoxifylline—Tremor—Estradiol—osteoporosis	0.000534	0.000981	CcSEcCtD
Pentoxifylline—Headache—Raloxifene—osteoporosis	0.000534	0.00098	CcSEcCtD
Pentoxifylline—Rash—Ibandronate—osteoporosis	0.000532	0.000977	CcSEcCtD
Pentoxifylline—Dermatitis—Ibandronate—osteoporosis	0.000531	0.000976	CcSEcCtD
Pentoxifylline—Dyspepsia—Zoledronate—osteoporosis	0.000531	0.000976	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00053	0.000973	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Estradiol—osteoporosis	0.000529	0.000971	CcSEcCtD
Pentoxifylline—Headache—Ibandronate—osteoporosis	0.000529	0.000971	CcSEcCtD
Pentoxifylline—Insomnia—Conjugated Estrogens—osteoporosis	0.000526	0.000966	CcSEcCtD
Pentoxifylline—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000525	0.000965	CcSEcCtD
Pentoxifylline—Vomiting—Calcitriol—osteoporosis	0.000525	0.000964	CcSEcCtD
Pentoxifylline—Decreased appetite—Zoledronate—osteoporosis	0.000525	0.000964	CcSEcCtD
Pentoxifylline—Agitation—Estradiol—osteoporosis	0.000524	0.000962	CcSEcCtD
Pentoxifylline—Nausea—Estropipate—osteoporosis	0.000523	0.00096	CcSEcCtD
Pentoxifylline—Abdominal pain—Pamidronate—osteoporosis	0.000522	0.000959	CcSEcCtD
Pentoxifylline—Body temperature increased—Pamidronate—osteoporosis	0.000522	0.000959	CcSEcCtD
Pentoxifylline—Angioedema—Estradiol—osteoporosis	0.000521	0.000957	CcSEcCtD
Pentoxifylline—Rash—Calcitriol—osteoporosis	0.000521	0.000956	CcSEcCtD
Pentoxifylline—Dermatitis—Calcitriol—osteoporosis	0.00052	0.000955	CcSEcCtD
Pentoxifylline—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000518	0.000952	CcSEcCtD
Pentoxifylline—Headache—Calcitriol—osteoporosis	0.000517	0.00095	CcSEcCtD
Pentoxifylline—Somnolence—Conjugated Estrogens—osteoporosis	0.000517	0.000949	CcSEcCtD
Pentoxifylline—Constipation—Zoledronate—osteoporosis	0.000516	0.000948	CcSEcCtD
Pentoxifylline—Nausea—Alendronate—osteoporosis	0.000515	0.000945	CcSEcCtD
Pentoxifylline—Malaise—Estradiol—osteoporosis	0.000514	0.000944	CcSEcCtD
Pentoxifylline—Hypersensitivity—Risedronate—osteoporosis	0.000512	0.000941	CcSEcCtD
Pentoxifylline—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000512	0.00094	CcSEcCtD
Pentoxifylline—Asthenia—Ethinyl Estradiol—osteoporosis	0.000512	0.00094	CcSEcCtD
Pentoxifylline—Nausea—Raloxifene—osteoporosis	0.000506	0.00093	CcSEcCtD
Pentoxifylline—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000505	0.000928	CcSEcCtD
Pentoxifylline—Pruritus—Ethinyl Estradiol—osteoporosis	0.000505	0.000927	CcSEcCtD
Pentoxifylline—Palpitations—Estradiol—osteoporosis	0.000504	0.000925	CcSEcCtD
Pentoxifylline—Nausea—Ibandronate—osteoporosis	0.000501	0.00092	CcSEcCtD
Pentoxifylline—Asthenia—Risedronate—osteoporosis	0.000499	0.000916	CcSEcCtD
Pentoxifylline—Feeling abnormal—Zoledronate—osteoporosis	0.000497	0.000914	CcSEcCtD
Pentoxifylline—Constipation—Conjugated Estrogens—osteoporosis	0.000497	0.000913	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Zoledronate—osteoporosis	0.000494	0.000907	CcSEcCtD
Pentoxifylline—Hypertension—Estradiol—osteoporosis	0.000492	0.000904	CcSEcCtD
Pentoxifylline—Pruritus—Risedronate—osteoporosis	0.000492	0.000903	CcSEcCtD
Pentoxifylline—Nausea—Calcitriol—osteoporosis	0.000491	0.000901	CcSEcCtD
Pentoxifylline—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000488	0.000896	CcSEcCtD
Pentoxifylline—Hypersensitivity—Pamidronate—osteoporosis	0.000487	0.000894	CcSEcCtD
Pentoxifylline—Chest pain—Estradiol—osteoporosis	0.000485	0.000891	CcSEcCtD
Pentoxifylline—Myalgia—Estradiol—osteoporosis	0.000485	0.000891	CcSEcCtD
Pentoxifylline—Anxiety—Estradiol—osteoporosis	0.000484	0.000888	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000482	0.000885	CcSEcCtD
Pentoxifylline—Urticaria—Zoledronate—osteoporosis	0.00048	0.000881	CcSEcCtD
Pentoxifylline—Discomfort—Estradiol—osteoporosis	0.00048	0.000881	CcSEcCtD
Pentoxifylline—Abdominal pain—Zoledronate—osteoporosis	0.000477	0.000876	CcSEcCtD
Pentoxifylline—Body temperature increased—Zoledronate—osteoporosis	0.000477	0.000876	CcSEcCtD
Pentoxifylline—Diarrhoea—Risedronate—osteoporosis	0.000476	0.000874	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000475	0.000873	CcSEcCtD
Pentoxifylline—Dry mouth—Estradiol—osteoporosis	0.000475	0.000872	CcSEcCtD
Pentoxifylline—Asthenia—Pamidronate—osteoporosis	0.000474	0.000871	CcSEcCtD
Pentoxifylline—Dizziness—Ethinyl Estradiol—osteoporosis	0.000472	0.000866	CcSEcCtD
Pentoxifylline—Confusional state—Estradiol—osteoporosis	0.000469	0.000861	CcSEcCtD
Pentoxifylline—Pruritus—Pamidronate—osteoporosis	0.000468	0.000859	CcSEcCtD
Pentoxifylline—Oedema—Estradiol—osteoporosis	0.000465	0.000854	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Estradiol—osteoporosis	0.000465	0.000854	CcSEcCtD
Pentoxifylline—Infection—Estradiol—osteoporosis	0.000462	0.000849	CcSEcCtD
Pentoxifylline—Urticaria—Conjugated Estrogens—osteoporosis	0.000462	0.000848	CcSEcCtD
Pentoxifylline—Dizziness—Risedronate—osteoporosis	0.00046	0.000844	CcSEcCtD
Pentoxifylline—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00046	0.000844	CcSEcCtD
Pentoxifylline—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00046	0.000844	CcSEcCtD
Pentoxifylline—Shock—Estradiol—osteoporosis	0.000458	0.000841	CcSEcCtD
Pentoxifylline—Tachycardia—Estradiol—osteoporosis	0.000454	0.000834	CcSEcCtD
Pentoxifylline—Vomiting—Ethinyl Estradiol—osteoporosis	0.000453	0.000833	CcSEcCtD
Pentoxifylline—Diarrhoea—Pamidronate—osteoporosis	0.000452	0.00083	CcSEcCtD
Pentoxifylline—Skin disorder—Estradiol—osteoporosis	0.000452	0.00083	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Estradiol—osteoporosis	0.00045	0.000826	CcSEcCtD
Pentoxifylline—Rash—Ethinyl Estradiol—osteoporosis	0.00045	0.000826	CcSEcCtD
Pentoxifylline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000449	0.000825	CcSEcCtD
Pentoxifylline—Headache—Ethinyl Estradiol—osteoporosis	0.000447	0.00082	CcSEcCtD
Pentoxifylline—Hypersensitivity—Zoledronate—osteoporosis	0.000445	0.000817	CcSEcCtD
Pentoxifylline—Vomiting—Risedronate—osteoporosis	0.000442	0.000812	CcSEcCtD
Pentoxifylline—Rash—Risedronate—osteoporosis	0.000438	0.000805	CcSEcCtD
Pentoxifylline—Dermatitis—Risedronate—osteoporosis	0.000438	0.000804	CcSEcCtD
Pentoxifylline—Dizziness—Pamidronate—osteoporosis	0.000437	0.000803	CcSEcCtD
Pentoxifylline—Headache—Risedronate—osteoporosis	0.000436	0.0008	CcSEcCtD
Pentoxifylline—Asthenia—Zoledronate—osteoporosis	0.000433	0.000795	CcSEcCtD
Pentoxifylline—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000428	0.000787	CcSEcCtD
Pentoxifylline—Pruritus—Zoledronate—osteoporosis	0.000427	0.000784	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000424	0.000778	CcSEcCtD
Pentoxifylline—Nausea—Ethinyl Estradiol—osteoporosis	0.000424	0.000778	CcSEcCtD
Pentoxifylline—Insomnia—Estradiol—osteoporosis	0.000421	0.000773	CcSEcCtD
Pentoxifylline—Vomiting—Pamidronate—osteoporosis	0.00042	0.000772	CcSEcCtD
Pentoxifylline—Asthenia—Conjugated Estrogens—osteoporosis	0.000417	0.000766	CcSEcCtD
Pentoxifylline—Rash—Pamidronate—osteoporosis	0.000417	0.000765	CcSEcCtD
Pentoxifylline—Dermatitis—Pamidronate—osteoporosis	0.000416	0.000765	CcSEcCtD
Pentoxifylline—Dyspnoea—Estradiol—osteoporosis	0.000415	0.000762	CcSEcCtD
Pentoxifylline—Headache—Pamidronate—osteoporosis	0.000414	0.00076	CcSEcCtD
Pentoxifylline—Somnolence—Estradiol—osteoporosis	0.000414	0.00076	CcSEcCtD
Pentoxifylline—Diarrhoea—Zoledronate—osteoporosis	0.000413	0.000759	CcSEcCtD
Pentoxifylline—Nausea—Risedronate—osteoporosis	0.000413	0.000758	CcSEcCtD
Pentoxifylline—Pruritus—Conjugated Estrogens—osteoporosis	0.000411	0.000755	CcSEcCtD
Pentoxifylline—Dyspepsia—Estradiol—osteoporosis	0.00041	0.000752	CcSEcCtD
Pentoxifylline—Decreased appetite—Estradiol—osteoporosis	0.000404	0.000743	CcSEcCtD
Pentoxifylline—Dizziness—Zoledronate—osteoporosis	0.000399	0.000733	CcSEcCtD
Pentoxifylline—Constipation—Estradiol—osteoporosis	0.000398	0.000731	CcSEcCtD
Pentoxifylline—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000398	0.00073	CcSEcCtD
Pentoxifylline—Nausea—Pamidronate—osteoporosis	0.000393	0.000721	CcSEcCtD
Pentoxifylline—Dizziness—Conjugated Estrogens—osteoporosis	0.000384	0.000706	CcSEcCtD
Pentoxifylline—Vomiting—Zoledronate—osteoporosis	0.000384	0.000705	CcSEcCtD
Pentoxifylline—Feeling abnormal—Estradiol—osteoporosis	0.000383	0.000704	CcSEcCtD
Pentoxifylline—Rash—Zoledronate—osteoporosis	0.000381	0.000699	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Estradiol—osteoporosis	0.00038	0.000699	CcSEcCtD
Pentoxifylline—Dermatitis—Zoledronate—osteoporosis	0.00038	0.000698	CcSEcCtD
Pentoxifylline—Headache—Zoledronate—osteoporosis	0.000378	0.000695	CcSEcCtD
Pentoxifylline—Vomiting—Conjugated Estrogens—osteoporosis	0.00037	0.000679	CcSEcCtD
Pentoxifylline—Urticaria—Estradiol—osteoporosis	0.00037	0.000679	CcSEcCtD
Pentoxifylline—Abdominal pain—Estradiol—osteoporosis	0.000368	0.000675	CcSEcCtD
Pentoxifylline—Body temperature increased—Estradiol—osteoporosis	0.000368	0.000675	CcSEcCtD
Pentoxifylline—Rash—Conjugated Estrogens—osteoporosis	0.000367	0.000673	CcSEcCtD
Pentoxifylline—Dermatitis—Conjugated Estrogens—osteoporosis	0.000366	0.000672	CcSEcCtD
Pentoxifylline—Headache—Conjugated Estrogens—osteoporosis	0.000364	0.000669	CcSEcCtD
Pentoxifylline—Nausea—Zoledronate—osteoporosis	0.000359	0.000659	CcSEcCtD
Pentoxifylline—Nausea—Conjugated Estrogens—osteoporosis	0.000345	0.000634	CcSEcCtD
Pentoxifylline—Hypersensitivity—Estradiol—osteoporosis	0.000343	0.000629	CcSEcCtD
Pentoxifylline—Asthenia—Estradiol—osteoporosis	0.000334	0.000613	CcSEcCtD
Pentoxifylline—Pruritus—Estradiol—osteoporosis	0.000329	0.000604	CcSEcCtD
Pentoxifylline—Diarrhoea—Estradiol—osteoporosis	0.000318	0.000585	CcSEcCtD
Pentoxifylline—Dizziness—Estradiol—osteoporosis	0.000308	0.000565	CcSEcCtD
Pentoxifylline—Vomiting—Estradiol—osteoporosis	0.000296	0.000543	CcSEcCtD
Pentoxifylline—Rash—Estradiol—osteoporosis	0.000293	0.000539	CcSEcCtD
Pentoxifylline—Dermatitis—Estradiol—osteoporosis	0.000293	0.000538	CcSEcCtD
Pentoxifylline—Headache—Estradiol—osteoporosis	0.000291	0.000535	CcSEcCtD
Pentoxifylline—Nausea—Estradiol—osteoporosis	0.000276	0.000507	CcSEcCtD
Pentoxifylline—PDE4A—GPCR downstream signaling—CALCA—osteoporosis	0.000205	0.000665	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ADCY5—osteoporosis	0.000204	0.000661	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PTH—osteoporosis	0.000203	0.000659	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—GPX1—osteoporosis	0.000203	0.000659	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IRS1—osteoporosis	0.000201	0.000653	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LRP6—osteoporosis	0.000199	0.000647	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PTHLH—osteoporosis	0.000198	0.000643	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CNR2—osteoporosis	0.000198	0.000643	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TLN1—osteoporosis	0.000198	0.000642	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LRP6—osteoporosis	0.000197	0.000639	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PTHLH—osteoporosis	0.000196	0.000635	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CALCA—osteoporosis	0.000192	0.000623	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CALCA—osteoporosis	0.00019	0.000616	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6R—osteoporosis	0.000189	0.000613	CbGpPWpGaD
Pentoxifylline—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000187	0.000609	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—MTHFR—osteoporosis	0.000187	0.000608	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CALCA—osteoporosis	0.000186	0.000604	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PTH—osteoporosis	0.000184	0.000599	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00018	0.000585	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CNR2—osteoporosis	0.00018	0.000584	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TLN1—osteoporosis	0.00018	0.000583	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—POMC—osteoporosis	0.000178	0.000577	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000176	0.000571	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CALCA—osteoporosis	0.000174	0.000566	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CALCA—osteoporosis	0.000172	0.000559	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000172	0.000559	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000171	0.000555	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—P4HB—osteoporosis	0.000171	0.000554	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—WNT1—osteoporosis	0.000169	0.000549	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PTHLH—osteoporosis	0.000168	0.000546	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TLN1—osteoporosis	0.000168	0.000546	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TLN1—osteoporosis	0.000166	0.00054	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTH—osteoporosis	0.000166	0.000539	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MGLL—osteoporosis	0.000165	0.000535	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RAP1A—osteoporosis	0.000163	0.00053	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000162	0.000526	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CNR2—osteoporosis	0.000162	0.000525	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TGFB1—osteoporosis	0.000161	0.000524	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LRP5—osteoporosis	0.000161	0.000522	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—ADCY5—osteoporosis	0.00016	0.000521	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NFATC1—osteoporosis	0.000159	0.000517	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DKK1—osteoporosis	0.000158	0.000513	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—P4HB—osteoporosis	0.000155	0.000503	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LRP6—osteoporosis	0.000154	0.000499	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PTHLH—osteoporosis	0.000153	0.000496	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—WNT1—osteoporosis	0.000152	0.000494	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000152	0.000493	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTH—osteoporosis	0.000151	0.000489	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—POMC—osteoporosis	0.00015	0.000486	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CALCA—osteoporosis	0.000148	0.000481	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RAP1A—osteoporosis	0.000148	0.000481	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGA—osteoporosis	0.000148	0.00048	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CNR2—osteoporosis	0.000147	0.000477	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—ADCY5—osteoporosis	0.000146	0.000473	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—ADCY5—osteoporosis	0.000146	0.000473	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—P4HB—osteoporosis	0.000145	0.000471	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—osteoporosis	0.000144	0.000469	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NFATC1—osteoporosis	0.000144	0.000469	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DKK1—osteoporosis	0.000143	0.000465	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—P4HB—osteoporosis	0.000143	0.000465	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTH—osteoporosis	0.000141	0.000458	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTH—osteoporosis	0.000139	0.000453	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAP1A—osteoporosis	0.000139	0.00045	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—WNT1—osteoporosis	0.000138	0.000448	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTHLH—osteoporosis	0.000137	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—BMP2—osteoporosis	0.000137	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CNR2—osteoporosis	0.000137	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—POMC—osteoporosis	0.000137	0.000445	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAP1A—osteoporosis	0.000137	0.000445	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—ADCY5—osteoporosis	0.000136	0.000443	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CNR2—osteoporosis	0.000136	0.000441	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NFATC1—osteoporosis	0.000135	0.000439	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—ADCY5—osteoporosis	0.000135	0.000438	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGB—osteoporosis	0.000135	0.000437	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CALCA—osteoporosis	0.000135	0.000437	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGA—osteoporosis	0.000134	0.000436	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	0.000134	0.000436	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DKK1—osteoporosis	0.000134	0.000436	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000134	0.000435	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NFATC1—osteoporosis	0.000134	0.000434	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000134	0.000434	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DKK1—osteoporosis	0.000133	0.000431	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000132	0.00043	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—ADCY5—osteoporosis	0.000132	0.00043	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PSMA2—osteoporosis	0.00013	0.000422	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PSMA5—osteoporosis	0.00013	0.000422	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TLN1—osteoporosis	0.00013	0.000422	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—WNT1—osteoporosis	0.000129	0.00042	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—WNT1—osteoporosis	0.000128	0.000415	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000126	0.000409	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGA—osteoporosis	0.000126	0.000408	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTHLH—osteoporosis	0.000125	0.000405	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—BMP2—osteoporosis	0.000125	0.000405	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000125	0.000405	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000125	0.000405	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGA—osteoporosis	0.000124	0.000404	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADCY5—osteoporosis	0.000124	0.000402	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000123	0.000399	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADCY5—osteoporosis	0.000122	0.000398	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGB—osteoporosis	0.000122	0.000397	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CALCA—osteoporosis	0.000121	0.000393	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—POMC—osteoporosis	0.000118	0.000383	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PSMA2—osteoporosis	0.000118	0.000383	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PSMA5—osteoporosis	0.000118	0.000383	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTHLH—osteoporosis	0.000117	0.00038	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—BMP2—osteoporosis	0.000117	0.00038	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTHLH—osteoporosis	0.000116	0.000375	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—BMP2—osteoporosis	0.000116	0.000375	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGB—osteoporosis	0.000114	0.000372	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGB—osteoporosis	0.000113	0.000367	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—P4HB—osteoporosis	0.000112	0.000364	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—osteoporosis	0.000112	0.000362	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PSMA2—osteoporosis	0.00011	0.000359	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PSMA5—osteoporosis	0.00011	0.000359	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KL—osteoporosis	0.00011	0.000357	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CALCA—osteoporosis	0.00011	0.000357	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000109	0.000355	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PSMA5—osteoporosis	0.000109	0.000354	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PSMA2—osteoporosis	0.000109	0.000354	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTH—osteoporosis	0.000109	0.000354	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—POMC—osteoporosis	0.000107	0.000348	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—POMC—osteoporosis	0.000107	0.000348	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAP1A—osteoporosis	0.000107	0.000348	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CNR2—osteoporosis	0.000106	0.000345	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADCY5—osteoporosis	0.000105	0.000342	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6R—osteoporosis	0.000105	0.00034	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NFATC1—osteoporosis	0.000104	0.000339	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DKK1—osteoporosis	0.000104	0.000336	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CALCA—osteoporosis	0.000103	0.000334	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CALCA—osteoporosis	0.000102	0.00033	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—POMC—osteoporosis	0.0001	0.000326	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KL—osteoporosis	9.98e-05	0.000324	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WNT1—osteoporosis	9.98e-05	0.000324	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—POMC—osteoporosis	9.92e-05	0.000322	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.81e-05	0.000319	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—POMC—osteoporosis	9.73e-05	0.000316	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGA—osteoporosis	9.71e-05	0.000315	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADCY5—osteoporosis	9.57e-05	0.000311	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6R—osteoporosis	9.5e-05	0.000308	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KL—osteoporosis	9.34e-05	0.000304	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KL—osteoporosis	9.23e-05	0.0003	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—POMC—osteoporosis	9.11e-05	0.000296	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BMP2—osteoporosis	9.03e-05	0.000293	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTHLH—osteoporosis	9.03e-05	0.000293	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—POMC—osteoporosis	9.01e-05	0.000293	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6R—osteoporosis	8.89e-05	0.000289	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGB—osteoporosis	8.83e-05	0.000287	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6R—osteoporosis	8.79e-05	0.000285	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADCY5—osteoporosis	8.61e-05	0.00028	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PSMA5—osteoporosis	8.53e-05	0.000277	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PSMA2—osteoporosis	8.53e-05	0.000277	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—osteoporosis	8.41e-05	0.000273	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.34e-05	0.000271	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SPP1—osteoporosis	8.33e-05	0.000271	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—POMC—osteoporosis	8.07e-05	0.000262	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CALCA—osteoporosis	7.95e-05	0.000258	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADCY5—osteoporosis	7.82e-05	0.000254	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—POMC—osteoporosis	7.75e-05	0.000252	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PKM—osteoporosis	7.61e-05	0.000247	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FDPS—osteoporosis	7.61e-05	0.000247	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SPP1—osteoporosis	7.56e-05	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IRS2—osteoporosis	7.53e-05	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LEP—osteoporosis	7.37e-05	0.000239	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADCY5—osteoporosis	7.32e-05	0.000238	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADCY5—osteoporosis	7.23e-05	0.000235	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KL—osteoporosis	7.22e-05	0.000234	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PGLS—osteoporosis	7.21e-05	0.000234	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPD2—osteoporosis	7.21e-05	0.000234	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SPP1—osteoporosis	7.08e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ESR1—osteoporosis	7.04e-05	0.000229	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—POMC—osteoporosis	7.04e-05	0.000229	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SPP1—osteoporosis	7e-05	0.000227	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6R—osteoporosis	6.86e-05	0.000223	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IRS2—osteoporosis	6.84e-05	0.000222	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LEP—osteoporosis	6.69e-05	0.000217	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PNP—osteoporosis	6.6e-05	0.000214	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ATIC—osteoporosis	6.6e-05	0.000214	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IRS1—osteoporosis	6.58e-05	0.000214	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IRS2—osteoporosis	6.4e-05	0.000208	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ESR1—osteoporosis	6.39e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—POMC—osteoporosis	6.33e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IRS2—osteoporosis	6.33e-05	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LEP—osteoporosis	6.27e-05	0.000204	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LEP—osteoporosis	6.19e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6R—osteoporosis	6.18e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1—osteoporosis	6.09e-05	0.000198	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ESR1—osteoporosis	5.98e-05	0.000194	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IRS1—osteoporosis	5.97e-05	0.000194	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ESR1—osteoporosis	5.91e-05	0.000192	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—POMC—osteoporosis	5.75e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADCY5—osteoporosis	5.65e-05	0.000184	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—OXCT1—osteoporosis	5.61e-05	0.000182	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA2—osteoporosis	5.61e-05	0.000182	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6R—osteoporosis	5.61e-05	0.000182	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IRS1—osteoporosis	5.59e-05	0.000182	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1—osteoporosis	5.53e-05	0.00018	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IRS1—osteoporosis	5.52e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SPP1—osteoporosis	5.47e-05	0.000178	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MGLL—osteoporosis	5.47e-05	0.000178	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—POMC—osteoporosis	5.38e-05	0.000175	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—POMC—osteoporosis	5.32e-05	0.000173	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6R—osteoporosis	5.25e-05	0.000171	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6R—osteoporosis	5.19e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1—osteoporosis	5.18e-05	0.000168	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.16e-05	0.000167	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1—osteoporosis	5.12e-05	0.000166	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IRS2—osteoporosis	4.95e-05	0.000161	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LEP—osteoporosis	4.84e-05	0.000157	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—osteoporosis	4.66e-05	0.000151	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—IDH2—osteoporosis	4.65e-05	0.000151	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ESR1—osteoporosis	4.62e-05	0.00015	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP27A1—osteoporosis	4.37e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IRS1—osteoporosis	4.32e-05	0.00014	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ACP5—osteoporosis	4.25e-05	0.000138	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—osteoporosis	4.23e-05	0.000137	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.2e-05	0.000136	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—osteoporosis	4.16e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6R—osteoporosis	4.06e-05	0.000132	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1—osteoporosis	4e-05	0.00013	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—osteoporosis	3.96e-05	0.000129	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TPI1—osteoporosis	3.95e-05	0.000128	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—osteoporosis	3.91e-05	0.000127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—P4HB—osteoporosis	3.72e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—osteoporosis	3.66e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—osteoporosis	3.65e-05	0.000119	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GAPDH—osteoporosis	3.65e-05	0.000118	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RAP1A—osteoporosis	3.55e-05	0.000115	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—osteoporosis	3.32e-05	0.000108	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—osteoporosis	3.32e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—osteoporosis	3.11e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—osteoporosis	3.1e-05	0.000101	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.1e-05	0.000101	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—osteoporosis	3.08e-05	9.99e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—osteoporosis	3.07e-05	9.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—osteoporosis	3.06e-05	9.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO1—osteoporosis	2.87e-05	9.33e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PSMA2—osteoporosis	2.83e-05	9.19e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PSMA5—osteoporosis	2.83e-05	9.19e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—osteoporosis	2.75e-05	8.94e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—osteoporosis	2.5e-05	8.12e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—osteoporosis	2.4e-05	7.81e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—osteoporosis	2.4e-05	7.79e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—osteoporosis	2.34e-05	7.6e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—osteoporosis	2.31e-05	7.51e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.3e-05	7.46e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADCY5—osteoporosis	1.88e-05	6.09e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPX1—osteoporosis	1.87e-05	6.07e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—osteoporosis	1.81e-05	5.87e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—osteoporosis	1.73e-05	5.6e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—osteoporosis	1.38e-05	4.48e-05	CbGpPWpGaD
